๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Specific Advanced Solid Tumors

A Study of GNC-077 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors NCT06609187Phase 11 site๐Ÿ“ Beijing Sichuan Baili Pharmaceutical Co., Ltd. ยท Tests: GNC-077 PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer NCT07426055Phase 2, Phase 31 site๐Ÿ“ Zamoล›ฤ‡ Affidea Nu-med Center of Oncological DIagnostics and Therapy ยท Tests: Stereotactic Body Radiotherapy (SBRT) Monotherapy, External Beam Radiotherapy (EBRT) Backbone, High-Dose-Rate Brachytheโ€ฆ Personalized Neoantigen Peptide Vaccines for Solid Tumors NCT07002203Phase 1, Phase 21 site๐Ÿ“ Bangkok Seqker Biosciences, Inc. ยท Tests: Personalized Neoantigen Peptide Vaccine EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors NCT06525298Phase 1, Phase 21 site๐Ÿ“ Houston Eisbach Bio GmbH ยท Tests: EIS-12656, Olaparib, Trastuzumab deruxtecan Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS NCT05379985Phase 1, Phase 221 sites๐Ÿ“ Orange๐Ÿ“ Santa Monica๐Ÿ“ Tampa Revolution Medicines, Inc. ยท Tests: RMC-6236 Dual-targeting CLDN18.2 and PD-L1 CAR-T for Patients with CLDN18.2-positive Advanced Solid Tumors NCT06084286Phase 11 site๐Ÿ“ Chengdu Sichuan University ยท Tests: Dual-targeting CLDN18.2 and PD-L1 CAR-T cells A Phase I Study of BAY3498264 Given Together With Sotorasib in Participants Who Have Advanced Solid Cancers With Specific Genetic Changes Called KRASG12C Mutation NCT06659341Phase 111 sites๐Ÿ“ Albury๐Ÿ“ Macquarie Park๐Ÿ“ Frankston Bayer ยท Tests: BAY3498264 Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors NCT07523529Phase 1, Phase 21 site๐Ÿ“ Shenzhen Beijing Biotech ยท Tests: Autologous dual-target CAR-T cells selected from the predefined target library., Fludarabine, Cyclophosphamide A Study of GNC-077 in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer and Other Solid Tumors NCT06612840Phase 11 site๐Ÿ“ Shanghai Sichuan Baili Pharmaceutical Co., Ltd. ยท Tests: GNC-077 PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer NCT07426094Phase 2, Phase 31 site๐Ÿ“ Zamoล›ฤ‡ Affidea Nu-med Center of Oncological DIagnostics and Therapy ยท Tests: Ultrahypofractionated Whole-Pelvis Radiotherapy, SBRT-Based Prostate Radiotherapy (No Boost), Ablative Prostate Boost, โ€ฆ A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors NCT05592626Phase 1, Phase 219 sites๐Ÿ“ Sacramento๐Ÿ“ Celebration๐Ÿ“ Miami Marengo Therapeutics, Inc. ยท Tests: STAR0602, Irinotecan (Camptosar), Docetaxel (Taxotere) A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit NCT06805825Phase 15 sites๐Ÿ“ Ann Arbor๐Ÿ“ Cleveland๐Ÿ“ Portland Novelty Nobility, Inc. ยท Tests: NN3201 Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS NCT07435038Phase 1, Phase 27 sites๐Ÿ“ Blacktown๐Ÿ“ Randwick๐Ÿ“ Sydney Betta Pharmaceuticals Co., Ltd. ยท Tests: BPI-572270 An Initial Evaluation of AN8025 in Solid Tumors NCT07639047Phase 11 site๐Ÿ“ Nedlands Adlai Nortye Biopharma Co., Ltd. ยท Tests: AN8025 is a multifunctional antibody fusion protein TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer NCT02693535Phase 2181 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Auburn American Society of Clinical Oncology ยท Tests: Sunitinib (CLOSED TO ENROLLMENT), Trastuzumab and Pertuzumab (CLOSED TO ENROLLMENT), Vemurafenib and Cobimetinib (CLOSEโ€ฆ First-in-Human Trial of VBC108 in Participants With Advanced Malignant Solid Tumors NCT07700160Phase 1, Phase 212 sites๐Ÿ“ Duarte๐Ÿ“ Grand Rapids๐Ÿ“ New York VelaVigo Bio Inc ยท Tests: VBC108 Study of ACR-2316 in Specific Advanced Solid Tumors NCT06667141Phase 1, Phase 215 sites๐Ÿ“ Phoenix๐Ÿ“ Beverly Hills๐Ÿ“ Newport Beach Acrivon Therapeutics ยท Tests: ACR-2316 First-in-Human Trial of VBC101 in Participants With Advanced Solid Tumor Malignancies NCT07136779Phase 1, Phase 25 sites๐Ÿ“ Grand Rapids๐Ÿ“ Houston๐Ÿ“ San Antonio VelaVigo Bio Inc ยท Tests: VBC101 HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors NCT06515314Phase 11 site๐Ÿ“ Shanghai Shanghai Ruiliyuan Biotechnology Co., Ltd. ยท Tests: AFP Specific T Cell Receptor T Cells T Cell Receptor T Cells for Advanced KRAS G12V-mutant Non-small Cell Lung Cancer, Pancreas Cancer, Colon Cancer NCT06043713Phase 11 site๐Ÿ“ Seattle Fred Hutchinson Cancer Center ยท Tests: Bendamustine, Biopsy, Biospecimen Collection, Computed Tomography, Cyclophosphamide High Dose Re-Irradiation Utilizing Advanced Deformable Image Registration (DIR) and Individualized Organ At Risk (OAR) Dose Calculations With Organ Specific Toxicity Analysis NCT05301101NA1 site๐Ÿ“ Milwaukee Medical College of Wisconsin ยท Tests: Re-irradiation GTB-5550 in Advanced Solid Tumors NCT07541573Phase 11 site๐Ÿ“ Minneapolis Masonic Cancer Center, University of Minnesota ยท Tests: GTB-5550 FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor Cancers NCT07638371Phase 17 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: MSK-TCR5 Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors NCT06005493Phase 1, Phase 225 sites๐Ÿ“ Jacksonville๐Ÿ“ Rochester๐Ÿ“ New York AstraZeneca ยท Tests: AZD5863, AZD2936 Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS NCT06895031Phase 21 site๐Ÿ“ Beijing Guangzhou JOYO Pharma Co., Ltd ยท Tests: JYP0015 Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors NCT03740256Phase 11 site๐Ÿ“ Houston Baylor College of Medicine ยท Tests: CAdVEC Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors NCT00900471n/a1 site๐Ÿ“ Winston-Salem Wake Forest University Health Sciences ยท Tests: biologic sample preservation procedure, medical chart review An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors NCT06942143Phase 11 site๐Ÿ“ Guangzhou Guangzhou FineImmune Biotechnology Co., LTD. ยท Tests: Super1 TCR-T A Study to Investigate Safety and Preliminary Efficacy of SOA101 in Adult Subjects With Advanced Solid Tumors NCT07055594Phase 1, Phase 21 site๐Ÿ“ Taichung Shine-On Biomedical Co., Ltd. ยท Tests: SOA101 NTRK Gene Fusion - Positive Advanced or Recurrent Solid Tumors, a Rare Cancer Caused by Specific Changes in the Genes NCT04945330n/a1 site๐Ÿ“ Multiple Locations Bayer ยท Tests: Larotrectinib (Vitrakvi, BAY2757556)
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy